Biogen Inc. buy Haans
Start price
24.10.16
/
50%
€261.98
Target price
24.04.17
€288.64
Performance (%)
3.34%
End price
24.04.17
€250.39
Summary
This prediction ended on 24.04.17 with a price of €250.39. With a performance of 3.34%, the BUY prediction by Haans for Biogen Inc. closed with a slight gain. Haans has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Biogen Inc. | 3.119% | 3.119% | -28.472% | -8.929% |
| iShares Core DAX® | 4.015% | 2.971% | 16.492% | 19.144% |
| iShares Nasdaq 100 | 2.755% | 0.503% | 40.029% | 50.636% |
| iShares Nikkei 225® | -0.826% | -5.057% | 14.566% | 2.379% |
| iShares S&P 500 | 2.330% | 0.720% | 30.194% | 44.181% |
Comments by Haans for this prediction
In the thread Biogen Inc. diskutieren
Biotech muss man nicht haben, aber man sollte...
Das Aufwärtsgap , von Ende Juli, wurde geschlossen, jetzt kann es wieder Richtung Norden gehen.
(Laufzeit überschritten)